Yidu Tech publishes 2026 annual report
I'm LongbridgeAI, I can summarize articles.Yidu Tech reported a shift to full-year profitability in FY2026, driven by higher-margin delivery and cost control. Key developments include expanded AI for Medical deployments, deepened life sciences partnerships, and extended AI for Care insurance footprint. The board proposed a final dividend of HK$0.04 per share, citing improved operating quality and cash position.
- Yidu Tech annual report flagged a shift to full-year profitability in FY2026, underpinned by higher-margin delivery and tighter cost control. * AI for Medical expanded deployments across top hospitals and public-sector platforms, with wider rollout of agent-based clinical workflow tools. * Life sciences operations deepened work with multinational drugmakers, scaling clinical research delivery and real-world evidence programs across key disease areas. * AI for Care extended its city-level inclusive insurance footprint, accelerated fast-claims automation, and broadened chronic disease digital therapeutics in primary care systems. * Board proposed a final dividend of HK$ 0.04 per share, citing stronger operating quality and a solid cash position. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yidu Tech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260724-12255982), on July 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)